Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-12

Clinical Trial Update: Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

Open-label randomized trial comparing cervical pessary vs vaginal progesterone to prevent preterm birth in women with a short cervix. Phase 2/Phase 3, status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cervical pessary (cervical pessary)
  • Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Preterm Birth, Short Cervix | Phase 2, Phase 3 | Status: UNKNOWN